跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺易 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Recombinant Coagulation Factor VIII for Injection
Approved
生物制品
Recombinant Coagulation Factor VIII for Injection
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Nov 5, 2025
Approval ID
887sloxg2WR
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
887sloxg2WR
Approval Number
国药准字SJ20200029
Generic Name
注射用重组人凝血因子Ⅷ
Generic Name En
Recombinant Coagulation Factor VIII for Injection
Trade Name
诺易
Drug Type
生物制品
Dosage Form
注射剂
Strength
1000IU/支
Reg Date
2025-11-05
Expired Date
2030-11-04
Company Name
Novo Nordisk A/S
Production Company Name
Novo Nordisk A/S
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 5, 2025
Approval ID
887sloxg2WR
Type
生物制品
Back to NMPA Approvals
